# FDA Inspection 1307896 - American Red Cross Blood Service - February 19, 2026

Source: https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-service/33c1907d-aa00-4f40-808f-2f0f956d656d
Source feed: FDA_Inspections

> FDA Inspection 1307896 for American Red Cross Blood Service on February 19, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1307896
- Company Name: American Red Cross Blood Service
- Inspection Date: 2026-02-19
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics

## Related Documents

- [FDA Inspection 1307896 - 2026-02-19](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-service/28932557-862f-432c-93b0-d5ac91940de9)
- [FDA Inspection 1090736 - 2019-05-01](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-service/e3aeed9c-690b-4825-a20a-1c4542f3e91f)
- [FDA Inspection 995155 - 2016-12-06](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-service/133f7851-64b9-4f82-abea-403f7ebada62)
- [FDA Inspection 933432 - 2015-07-07](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-service/5bb922e5-ccc9-4b95-a81a-98e4278145f4)
- [FDA Inspection 824506 - 2013-03-26](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-service/f005fb7f-ab5d-4798-bc3d-6c33f83eb770)

Company: https://www.keypedia.com/companies/american-red-cross-blood-service/f3b9d503-7705-4131-9dc4-647112fadf40